0 items
Your cart is empty.
Mitochondria are widely known for producing ATP, but they also participate in complex signalling networks that influence how cells respond to energy status and stress. MOTS-c is a peptide studied within this context.
MOTS-c is a short peptide encoded within the mitochondrial genome. Because it originates from mitochondrial DNA, researchers classify it as a mitochondrial-derived peptide. A peptide is a chain of amino acids, and the mitochondrial genome is the genetic material located inside mitochondria.
MOTS-c was first characterised in depth by Lee et al. (2015), who described it as a peptide encoded within mitochondrial 12S ribosomal RNA. That foundational study reported that MOTS-c could influence metabolic markers in cell culture and in mouse models. However, those findings are preclinical. They describe laboratory observations, not established effects in humans.
In research settings, MOTS-c is studied primarily in cell culture systems. These are controlled laboratory environments where cells are maintained outside a living organism. Researchers use such systems to examine how MOTS-c interacts with cellular pathways under defined conditions. The peptide remains an experimental compound intended for in-vitro laboratory use only.
Mitochondrial-derived peptides are a growing area of study. They are small protein fragments encoded by mitochondrial DNA. Their existence suggests that mitochondria do more than produce energy; they may also send molecular signals to the rest of the cell. This process is part of mitochondrial signalling.
Kim et al. (2017) reviewed mitochondrial-derived peptides, including MOTS-c, humanin, and small humanin-like peptides. The review explains that these peptides may act as signalling molecules involved in metabolic regulation. The Elivena brief similarly positions mitochondrial signalling as a research domain that focuses on molecular messages moving between mitochondria and other cellular compartments.
In laboratory research, MOTS-c is added to culture media, and researchers then measure changes in gene expression or protein activity. Gene expression is the process by which information from a gene is used to make a functional product. These measurements help scientists investigate whether MOTS-c participates in mitochondrial communication. The key point is that this work is exploratory and does not involve human subjects.
One major focus of MOTS-c research is the AMPK pathway. AMPK stands for AMP-activated protein kinase. It is an enzyme that helps cells sense energy levels. Hardie et al. (2012) provide a comprehensive review of AMPK as a nutrient and energy sensor that maintains energy homeostasis. Hardie (2014) later summarised how AMPK interacts with other signalling pathways.
The AMPK pathway is central to metabolic research because it helps cells respond to changes in energy availability. When cellular energy levels fall, AMPK activity can shift to restore balance. Researchers study MOTS-c in relation to this pathway because foundational work by Lee et al. (2015) reported changes in AMPK phosphorylation after MOTS-c exposure in certain experimental models. However, those results are preclinical observations. They do not prove that MOTS-c directly activates or inhibits AMPK in all contexts.
In laboratory experiments, scientists can activate or inhibit the AMPK pathway using pharmacological or genetic tools. They then observe whether MOTS-c changes the cellular response. This type of experiment is common in peptide research because it helps isolate a peptide’s potential role in a specific pathway. The findings are interpreted cautiously and are not translated into claims about metabolic health, weight, or performance.
Researchers use several laboratory models to study MOTS-c. These include immortalized cell lines and primary cells. Immortalized cell lines can divide many times in culture and are convenient for repeated experiments. Primary cells are taken directly from tissue and have a limited lifespan in culture. Each model has strengths and limitations.
A typical in-vitro study includes a control group that does not receive the peptide and a treated group that receives MOTS-c at a defined concentration. Researchers then compare the two groups. They may measure ATP levels, mitochondrial respiration, or specific protein markers. Western blotting is used to detect proteins, and quantitative PCR is used to measure gene expression. These methods are standard in peptide research.
Although some peer-reviewed studies have used animal models to examine MOTS-c, the Elivena brief focuses on in-vitro cellular energy models. Therefore, this article emphasises cell culture and laboratory-based research. Any extrapolation from cell culture to whole organisms is beyond the scope of the brief.
Current research on MOTS-c covers several directions. One direction is mitochondrial stress, which occurs when mitochondria are damaged or overloaded. Another direction is nutrient sensing, the process by which cells detect available nutrients and adjust metabolism. Researchers also investigate the relationship between MOTS-c and oxidative phosphorylation, the process by which cells make ATP using oxygen.
The peer-reviewed literature provides context for these directions. Lee et al. (2015) reported that MOTS-c influenced metabolic gene expression in cell and mouse models. Kim et al. (2017) reviewed how mitochondrial-derived peptides may regulate metabolism. Hardie et al. (2012) and Hardie (2014) explain how AMPK integrates energy signals. Together, these sources support the rationale for studying MOTS-c in mitochondrial signalling, but they do not establish clinical relevance.
Researchers should also be aware that many questions remain unanswered. The precise molecular targets of MOTS-c, its stability under different conditions, and its relevance across cell types are still being investigated. The source brief specifically instructs that no metabolism, weight, or performance claims should be made. All statements should be limited to laboratory research.
Laboratories studying mitochondrial signalling need reliable peptide sources. Elivena offers MOTS-c 10mg research peptide for in-vitro applications. The product page provides details on purity, storage, and handling. Researchers should always follow institutional guidelines and confirm that the peptide meets their experimental requirements.
For laboratories that need a larger quantity per vial, the MOTS-c 20mg research peptide may be a practical option. Suggested related article topics include SS-31 in Mitochondrial Research Models, AMPK Pathway Research and Metabolic Peptides, and NAD+ in Cellular Energy Research.
Every study involving MOTS-c must follow research-use-only rules. These rules are mandatory. The information in this article describes what MOTS-c is and how it is studied. It does not describe what MOTS-c does in a person. It does not provide dosing information. It does not suggest therapeutic benefits.
For research use only. This content is provided for in-vitro laboratory research purposes. The compounds discussed are not for human consumption and are not approved by the FDA or EMA to prevent, treat, or cure any condition. Introduction into humans or animals is prohibited by law.
Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251-262. doi:10.1038/nrm3311
Hardie DG. AMPK—sensing energy while talking to other signaling pathways. Cell Metab. 2014;20(6):939-952. doi:10.1016/j.cmet.2014.09.013
Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613-6621. doi:10.1113/JP274472
Lee C, Zeng J, Drew BG, et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metab. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009
Unlock savings on bundles and elevate your online experience today!